Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes

Hepatology

Volumn 26, Issue 3, 1997, Pages 598-604

  Tanaka, Shinji ^a,c   Mohr, Leonhard ^a   Schmidt, Emmett V ^a   Sugimachi, Keizo ^b   Wands, Jack R ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0030769166     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260310     Document Type: Article

References (42)

1. Moradpour D, Wands JR. Hepatic Oncogenesis. In: Zakim D, Boyer T, eds. Hepatology. 3rd Ed. Philadelphia: WB Saunders, 1996:1490-1512.
2. Nishiyama M, Wands JR. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 1992;183:280-285.
3. Welham MJ, Learmonth L, Bone H, Scrader JW. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J Biol Chem 1995; 270:12286-12296.
4. Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 1995;270:14685-14692.
5. Platanias LC, Uddin S, Yetter A, Sun XJ, White MF. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem 1996;271:278-282.
6. Guo D, Donner DB. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 1996;271:615-618.
7. Sasaki Y, Zhang XF, Nishiyama M, Avruch J, and Wands JR. Expression and phosphorylation of insulin receptor substrate 1 during rat liver regeneration. J Biol Chem 1993;268:3805-3808.
8. Baltensperger K, Kozma LM, Cherniack AD, Klarlund JK, Chawla A, Banerjee U, Czech MP. Binding of ras activator son of sevenless to insulin receptor substrate-1 signaling complex. Science 1993;260:1950-1952.
9. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, et al. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 1993;260:1953-1955.
10. Kuhne MR, Pawson T, Lienhard GE, Feng GS. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 1993;268:11479-11481.
11. Backer JM, Myers MG Jr, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 1992;11:3469-3479.
12. Myers MG Jr., Backer JM, Sun XJ, Shoelson S, Hu P, Schlessinger J, Yoakim M, et al. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci U S A 1992;89:10350-10354.
13. Myers MG Jr., Sun XJ, White MF. The IRS-1 signaling system. Trends Biochem Sci 1994;19:289-293.
14. White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994; 269:1-4.
15. Ito T, Sasaki Y, Wands JR. Overexpression of the human insulin receptor substrate-1 (hIRS-1) gene induces cellular transformation through mitogen-activated protein kinases (MAPKs). Mol Cell Biol 1996;16:943-951.
16. Tanaka S, Ito T, Wands JR. Neoplastic transformation induced by insulin receptor substrate-1 (IRS-1) overexpression requires an interaction with both Grb2 and Syp signaling molecules. J Biol Chem 1996;271: 14610-14616
17. Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994;77:841-852.
18. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukusawa K, Van de Woude GF, et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265:966-970.
19. Zaret KS, DiPersio CM, Jackson DA, Montigny WJ, Weinstat DL. Conditional enhancement of liver-specific gene transcription. Proc Natl Acad Sci U S A 1988;85:9076-9080.
20. Nishiyama M, Inazawa J, Ariyama T, Nakamura Y, Matsufuji S, Furusaka A, Tanaka T, et al. The human insulin receptor substrate-1 gene (IRS1) is localized on 2q36. Genomics 1994;20:139-141.
21. Mulligan RC, Berg P. Expression of a bacterial gene in mammalian cells. Science 1980;209:1422-1427.
22. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A 1992;89:373-377.
23. Sasaki Y, Wands JR. Ethanol impairs insulin receptor substrate-1 mediated signal transduction during rat liver regeneration. Biochem Biophys Res Commun 1994;199:403-409.
24. Current Protocols in Molecular Biology, 1995, John Wiley & Sons, Inc.
25. Fredericks WM, Marx F, Chameleau RAFM, van Noorden CJF, James J. Immunocytochemical determination of ploidy class-dependent bromodeoxyuridine incorporation in rat liver parenchymal cells after partial hepatectomy. Histochemistry 1990;93:627-630.
26. Pawson T. Protein modules and signaling networks. Nature 1995;373: 573-580.
27. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65:311-320.
28. Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR, and Avruch J. Raf-1 activates MAP kinase-kinase. Nature 1992;358: 417-421.
29. Zhang XF, Settleman J, Kyriakis JM, Takeuchi-Suzuki E, Elledge SJ, Marshall MS, Bruder JT, et al. Normal and oncogenic p21 ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 1993; 364:308-313.
30. Cobb MH, and Goldsmith EJ. How MAP kinase are regulated. J Biol Chem 1995;270:14843-14846.
31. Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated ras activation. Mol Cell Biol 1994;14:6674-6682.
32. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci U S A 1995;92:664-668.
33. Milarski K, and Saltiel AR. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein-kinase by insulin. J Biol Chem 1994;269:21239-21243.
34. Xiao S, Rose DW, Sasaoka T, Maegawa H, Burke TR Jr, Roller PP, Shoelson SE, et al. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem 1994;269: 21244-21248.
35. Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 1995;268:100-102.
36. Sasaoka T, Rose DW, Jhun BH, Salteil AR, Draznin B, Olefsky JM. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem 1994;269:13689-13694.
37. ras-GTP formation. J Biol Chem 1994;269:10734-10738.
38. Tanaka S, Wands JR. A carboxy-terminal truncated dominant negative protein IRS-1 protein reverses the human hepatocellular carcinoma malignant phenotype. J Clin Invest 1996;98:2100-2108.
39. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270:1326-1331.
40. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995;267: 2003-2006.
41. Tanaka S, Wands JR. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor β 1-induced apoptosis. Cancer Research 1996;56:3391-3394.
42. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996;379:88-91.